Skip to main content

Applied Real Intelligence Adds To Advisory Board

Venture debt investment manager Applied Real Intelligence has expanded its Advisory Board, adding Randy Cohen, Dan Espinal, Edward Finn, Laura Hope, Johnita Walker Mizelle, Julianne Recine, Blair Smith, Jamil Soriano, and Ben Wiles. The initial members of A.R.I.’s Advisory Board were announced in October 2020 and included Cynthia Bai, Jonathan Easton, Susan Estes, Courtney Hall, Roy Lowrance, and Guy Pinkman. 

“The fifteen executives on A.R.I.’s Advisory Board are composed of a broad and diverse group of globally-renowned leaders who will serve as a best-in-class example for the industry going forward. A.R.I. has prioritized leadership, integrity, diversity, risk-intelligence, and specific business expertise that will help us to reduce risk and rapidly grow our venture debt investment platform,” said Zack Ellison, A.R.I.’s Managing General Partner and Chief Investment Officer.

“As the former manager of New York Common Retirement Fund’s $5.2bn Emerging Manager Program, and the current head of a consulting firm focused on advising leading asset managers and investors, I look forward to helping A.R.I. successfully navigate the emerging manager landscape with its flagship Venture Debt Opportunities Fund,” said Blair Smith, Founder and CEO, Promethean AB Strategies.

“I am honoured to join A.R.I.’s Advisory Board to help Zack Ellison build a firm where true alignment of interests, diversity, and inclusion are integral parts of its corporate DNA,” said Johnita Walker Mizelle, Head of Investor Relations for Anthemis and Chair of the Board of Directors for The Council of Urban Professionals.

"As a former VC and current founder, I’ve experienced first-hand the gaps in the debt financing market for innovative high-growth companies. I'm excited to help A.R.I. fund companies, and support founders, that don't fit the traditional bank underwriting model," said Dan Espinal, Co-Founder and CEO, Rarebreed Veterinary Partners.


© The Sortino Group Ltd

All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.